ATBdiscrimination
ATBdiscrimination classifies active tuberculosis (ATB) versus latent tuberculosis infection (LTBI) using 36 blood biochemical parameters and T-SPOT.TB detection results.
Key Features:
- Data Integration: Integrates 36 blood biochemical parameters with T-SPOT.TB detection results from routine clinical practice.
- Algorithmic Approach: Uses the random forest algorithm to develop a classifier distinguishing ATB from LTBI.
- Performance Metrics: Demonstrates AUC = 0.9256 on cross-validation and AUC = 0.8731 on external validation.
Scientific Applications:
- Clinical Diagnosis: Identification of active TB from routine blood tests and T-SPOT.TB results to inform patient management.
- Research Insights: Investigation of associations between tuberculosis infection status and routine blood biochemical parameters plus T-SPOT.TB results.
Methodology:
Model trained on data from 478 patients comprising 36 blood biochemical parameters and T-SPOT.TB results using a random forest classifier evaluated by cross-validation and external validation (AUCs 0.9256 and 0.8731, respectively).
Topics
Details
- Added:
- 1/9/2020
- Last Updated:
- 12/2/2020
Operations
Publications
Wu J, Bai J, Wang W, Xi L, Zhang P, Lan J, Zhang L, Li S. ATBdiscrimination: An in Silico Tool for Identification of Active Tuberculosis Disease Based on Routine Blood Test and T-SPOT.TB Detection Results. Journal of Chemical Information and Modeling. 2019;59(11):4561-4568. doi:10.1021/acs.jcim.9b00678. PMID:31609612.